TWIST1 and neoplasm: Our findings illustrate a spatially regulated mechanism by which the vascular niche fuels pro-tumor immunity and suggest that targeting endothelial Twist1 may represent a promising strategy for enhancing the efficacy of T cell–based immunotherapy.